Zidovir 100 mg (Zidovudine)

Product Overview

Zidovir 100 mg is a prescription antiretroviral medication manufactured by Cipla Limited. It is formulated as Zidovudine, a cornerstone drug in the treatment of HIV infection. The product is supplied in two convenient pack formats: 10 tablets per strip and 10 capsules per strip, each strip containing a total of 30, 60, or 90 capsules depending on the selected pack size. This packaging ensures stability and ease of administration for patients managing chronic HIV therapy. Classified under the therapeutic area of HIV‑Aids, Zidovir is indicated for adults and adolescents who require combination antiretroviral therapy. The medication is intended for oral use and should be stored at room temperature, away from moisture and heat. Shipping typically occurs within 6 to 15 days, ensuring a reliable supply for long‑term treatment regimens. The formulation adheres to stringent quality standards set by the Indian regulatory authorities and complies with international Good Manufacturing Practice (GMP) guidelines, guaranteeing consistency and potency across batches.

What is Zidovir 100 mg (Zidovudine)

Zidovir belongs to the nucleoside reverse transcriptase inhibitor (NRTI) family. Its active ingredient, Zidovudine, works by being phosphorylated intracellularly to zidovudine monophosphate, which then competes with deoxythymidine triphosphate (dTTP) for incorporation into the growing viral DNA chain. Once incorporated, the chain terminator prevents further elongation, effectively halting viral replication. This mechanism makes Zidovir a potent component of highly active antiretroviral therapy (HAART). Zidovudine was one of the first FDA‑approved drugs for HIV and remains a reference agent in many global treatment guidelines. The 100 mg strength provides a standardized dose that can be adjusted based on patient weight, renal function, and concomitant medications.

Uses and Benefits

Clinically, Zidovir 100 mg is employed as part of a combination regimen to reduce viral load and preserve CD4⁺ T‑cell counts in individuals living with HIV. When paired with other antiretrovirals such as lamivudine or efavirenz, it contributes to sustained viral suppression and improved long‑term prognosis. The medication is also utilized in prevention strategies for mother‑to‑child transmission when administered during pregnancy and lactation under medical supervision. Patients often experience a reduction in HIV‑related symptoms and a lower risk of opportunistic infections, translating into enhanced quality of life. Real‑world studies have demonstrated that early initiation of Zidovudine‑containing regimens can decrease the incidence of AIDS‑defining events by up to 50 percent compared with deferred therapy. Moreover, the drug’s established safety profile and availability in multiple pack sizes facilitate tailored treatment plans for diverse patient populations.

How It Works

Zidovudine functions as a Competitive Inhibitor of the HIV reverse transcriptase enzyme. After oral administration, the drug is metabolized in the liver to its active triphosphate form, which mimics thymidine and becomes incorporated into viral DNA. This incorporation leads to premature termination of the DNA strand, preventing the virus from completing its replication cycle. Because the active metabolite is preferentially retained in infected cells, the intracellular concentration of the active form is higher in HIV‑positive cells, enhancing antiviral efficacy while limiting exposure of uninfected cells. The selective activation in infected cells is due to the presence of viral reverse transcriptase, which phosphorylates Zidovudine more efficiently than host enzymes, underscoring its advantage as a cornerstone therapy in both treatment‑naïve and treatment‑experienced patients.

Dosage Guidelines

For most adult patients, the recommended dosage of Zidovir 100 mg is one tablet taken orally twice daily, preferably at evenly spaced intervals to maintain steady plasma concentrations. In patients with renal impairment (creatinine clearance < 10 mL/min), the dosing interval may be extended to three times per week, but this adjustment should only be made under physician supervision. Pediatric dosing is weight‑based and typically expressed as 1 mg per kilogram of body weight per dose, administered twice daily. The medication should be taken with or without food, as food does not significantly affect absorption. It is essential to complete the full prescribed course, even if clinical improvement is observed early, to minimize the risk of developing resistant viral strains. If a dose is missed, the patient should take it as soon as remembered unless it is near the time of the next scheduled dose; in that case, the missed dose should be skipped and the regular schedule resumed. Consistency in dosing enhances therapeutic outcomes and reduces the likelihood of viral rebound.

Side Effects

The most frequently reported adverse events include nausea, headache, fatigue, and mild anemia. Some patients may experience myelosuppression, manifested as decreased white blood cell or platelet counts, which usually resolves with dose modification. Rare but serious complications can involve hepatic dysfunction, indicated by elevated transaminases, and severe hypersensitivity reactions such as Stevens‑Johnson syndrome. Long‑term use may be associated with mitochondrial toxicity, potentially leading to peripheral neuropathy or myopathy. Patients should be monitored regularly for signs of bone marrow suppression, particularly if they have pre‑existing cytopenias or are receiving concomitant myelosuppressive agents. Clinical trials have shown that the incidence of severe neutropenia is low when Zidovir is used in combination with modern antiretrovirals, but vigilance is warranted in high‑risk populations. Adjustments of dosage may be required in patients with advanced liver disease.

Warnings and Precautions

Prior to initiating Zidovir therapy, clinicians should obtain a comprehensive medical history, focusing on hepatic or renal disease, prior bone marrow disorders, and concomitant medications that may interact with zidovudine. The drug is contraindicated in patients with known hypersensitivity to Zidovudine or any of the excipients. Caution is advised when co‑administering with other myelosuppressive agents, such as chemotherapy or trimethoprim‑sulfamethoxazole, as additive hematologic toxicity may occur. Pregnant women should only use Zidovir if the potential benefit justifies the potential risk to the fetus, and dosing should be aligned with public health recommendations for prevention of vertical transmission. Regular laboratory monitoring, including CBC and liver function tests, is recommended every 4–6 weeks during the first six months of therapy. Patients should be educated about the importance of adherence and the signs of adverse reactions that warrant immediate medical attention, such as persistent fever, unexplained bruising, or severe skin rash. For detailed prescribing information, refer to the FDA label or consult a healthcare professional.

FAQs

1. Q: What is the recommended storage condition for Zidovir 100 mg? A: Store at room temperature, 15‑30 °C, away from direct sunlight and moisture. Keep the strip sealed until use.
2. Q: Can Zidovir be taken with other HIV medications? A: Yes, it is commonly combined with other antiretrovirals such as lamivudine or efavirenz, but the full regimen should be prescribed by a healthcare professional.
3. Q: Is Zidovir safe during pregnancy? A: Zidovir is classified as pregnancy category C; it may be used when the expected benefit outweighs the risk, typically under medical supervision for mother‑to‑child transmission prevention.
4. Q: How long does shipping take for Zidovir orders? A: Standard delivery within the United States typically requires 6 to 15 business days after order confirmation.
5. Q: What should I do if I miss a dose? A: Take the missed dose as soon as you remember, unless it is almost time for the next scheduled dose; then skip the missed dose and continue with the regular schedule.

Overall, Zidovir 100 mg offers a reliable, evidence‑based option for individuals seeking effective HIV management. Its proven efficacy, convenient dosing schedule, and robust supply chain make it a trusted choice for both patients and clinicians.